Medios AG (MEDOF)
OTC Markets OTCPK · USD · Healthcare · Medical Distribution
$50.00 (+0.00%) as of
Key statistics
- Market cap
- 1.28B
- P/E (TTM)
- 70.42
- EPS (TTM)
- 0.71
- 52-week range
- 13.64 – 50.00
- Beta
- 1.26
- Revenue (TTM)
- 2.16B
- Profit margin
- 0.52%
- Volume
- 2.00k
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Berlin, Germany
- Employees
- 989
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.